Literature DB >> 3667831

Liquid chromatographic assay for the simultaneous determination of pyrazinamide and rifampicin in serum samples from patients with tuberculous meningitis.

J Woo1, C L Wong, R Teoh, K Chan.   

Abstract

A simple high-performance liquid chromatographic assay for the simultaneous determination of pyrazinamide and rifampicin in serum from patients with tuberculous meningitis is presented. The drugs and internal standard, p-acetamidobenzoic acid, were extracted from the acidified sample containing 2% ascorbic acid at pH 4.2 into dichloromethane-diethyl ether (2:3). The solvent extract was evaporated to dryness with the aid of nitrogen and the residue redissolved in methanol (75 microliters). The concentrate was analysed by a liquid chromatograph using a reversed-phase 30-microns C8 pre-column linked to a 5-microns C8 analytical column with a gradient solvent programme, which delivered 6% to 48% (v/v) acetonitrile in phosphate buffer (10 mM potassium dihydrogenphosphate, pH 3.5) in 10 min at 1.5 ml/min. The eluate was detected at 215 nm. Twelve patients with tuberculous meningitis were given daily chemotherapy, and their serum samples were assayed for pyrazinamide and rifampicin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3667831     DOI: 10.1016/0378-4347(87)80156-1

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

1.  Slow release formulations of inhaled rifampin.

Authors:  Intira Coowanitwong; Vikram Arya; Poj Kulvanich; Günther Hochhaus
Journal:  AAPS J       Date:  2008-06-27       Impact factor: 4.009

2.  Simultaneous microdetermination of rifampin, deacetylrifampin, isoniazid, and acetylisoniazid in plasma by liquid chromatography with dual electrochemical and spectrophotometric detection.

Authors:  A el-Yazigi; D A Raines
Journal:  Pharm Res       Date:  1992-06       Impact factor: 4.200

3.  Quantification of rifampicin in human plasma and cerebrospinal fluid by a highly sensitive and rapid liquid chromatographic-tandem mass spectrometric method.

Authors:  Abhishek Srivastava; David Waterhouse; Alison Ardrey; Stephen A Ward
Journal:  J Pharm Biomed Anal       Date:  2012-06-01       Impact factor: 3.935

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.